Venkatesh Brahma, MD
Ophthalmology · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 11 years
- Graduated 2015
Offices
1 location · Eye Care Institute A Medical Corporation · 8 clinicians in this group
Looking this up.
Hospitals listed: Providence Santa Rosa Memorial Hospital. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Brahma’s office at (707) 546-9800 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
State licence records
1 licence
- New Jersey 25MA10896300Medical Doctor · since 2020 · expires 2023-06-30InactiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Providence Santa Rosa Memorial HospitalSanta Rosa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.375, Oct 2024 – Sep 2025
See every measure and the patient survey for Providence Santa Rosa Memorial Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.26 to 2.13) · 1,736 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.76 (0.48 to 1.03) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.27 (137.92 to 224.62) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 129 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 530 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.2 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.3 · 245 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 2,733 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.4) · 8,115 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,057 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.37 (0.56 to 4.18) · 2,186 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0.1 to 3.08) · 772 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.9 to 3.63) · 1,999 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 5.74 (0.06 to 11.42) · 810 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.04 (0.53 to 7.55) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.8 (0.38 to 3.21) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.46 (0 to 1) · 7,051 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 77 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.915 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.552 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.297 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.353 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 489 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 0.4 · 259 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -0.4 · 580 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.5 · 456 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 431 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.4 (4.9 to 8.3) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.3 (8.2 to 12.7) · 584 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 72 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.8 to 16.7) · 2,810 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 780 cases | No different | Jan 2024 – Dec 2024 |
What patients said (473 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 37% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$389,780
Medicare paid this office $389,780 for 1,081 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of cataract with insertion of prosthetic lens | 131 | $108,832 | $475 |
| Established patient complete exam of visual system | 459 | $46,285 | $96 |
| Established patient problem focused exam of visual system | 367 | $42,153 | $75 |
| Return visit (30+ min) | 271 | $31,959 | $102 |
| Removal of recurring cataract in lens capsule using a laser | 68 | $24,990 | $352 |
See all 22 services
| Removal of cataract with insertion of prosthetic lens | 131 | $108,832 | $475 |
| Established patient complete exam of visual system | 459 | $46,285 | $96 |
| Established patient problem focused exam of visual system | 367 | $42,153 | $75 |
| Return visit (30+ min) | 271 | $31,959 | $102 |
| Removal of recurring cataract in lens capsule using a laser | 68 | $24,990 | $352 |
| New patient complete exam of visual system | 198 | $20,265 | $102 |
| New patient visit (45+ min) | 144 | $18,208 | $126 |
| Complex removal of cataract with insertion of prosthetic lens | 18 | $15,857 | $661 |
| Imaging of retina | 368 | $15,371 | $33 |
| Exam of visual field with extended testing | 173 | $15,256 | $57 |
| Measurement of corneal curvature and depth of eye | 172 | $9,325 | $33 |
| Imaging of optic nerve | 201 | $8,726 | $29 |
| Exam of the internal drainage system of eye | 390 | $8,632 | $22 |
| Closure of tear duct opening using plug | 20 | $5,371 | $103 |
| Long return visit (40+ min) | 22 | $3,509 | $153 |
| New patient visit (60+ min) | 18 | $3,016 | $168 |
| Exam to measure eye deviation and range of motion | 40 | $2,426 | $55 |
| New patient problem focused exam of visual system | 14 | $1,042 | $74 |
| Short return visit (20+ min) | 12 | $910 | $76 |
| Ct scan of cornea | 12 | $352 | $29 |
| Removal of eyelashes using forceps | 13 | $302 | $18 |
| Ultrasound scan of cornea to determine thickness | 16 | $156 | $9 |
Procedures Medicare counted
| Cataract surgery | 396 | More than 93% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of cataract with insertion of prosthetic lens | – | – | 58 | 57 | 182 | 229 |
| Removal of recurring cataract in lens capsule using a laser | – | – | – | 15 | 61 | 71 |
| Closure of tear duct opening using plug | – | – | – | – | – | 52 |
| Complex removal of cataract with insertion of prosthetic lens | – | – | – | – | 18 | 24 |
| Removal of eyelashes using forceps | – | – | – | – | 16 | 17 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,081 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 13% · Women 61% · Also on Medicaid 23% · Health risk score 1.16. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 63% · Diabetes 24% · Depression 22% · Coronary heart disease 21% · Chronic kidney disease 18% · Atrial fibrillation 17% · Cancer 15% · Heart failure 12% · COPD 11% · Stroke 10% · Dementia 5%.
The office billed $1,623,754, Medicare allowed $533,921 and paid $389,780; for 3,982 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,081 | 3,982 | 75 | 1.16 | $1,623,754 | $389,780 |
| 2023 | 886 | 3,150 | 75 | 1.16 | $1,272,600 | $304,718 |
| 2022 | 653 | 1,861 | 75 | 1.24 | $587,407 | $158,481 |
| 2021 | 480 | 1,620 | 74 | 1.21 | $484,216 | $138,980 |
| 2020 | 119 | 241 | 73 | 1.49 | $58,281 | $17,231 |
| 2019 | 21 | 25 | 66 | 2.13 | $3,583 | $1,398 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Removal of cataract with insertion of prosthetic lens | 107 | $84,610 | $465 |
| Established patient problem focused exam of visual system | 296 | $33,441 | $73 |
| Established patient complete exam of visual system | 314 | $33,188 | $96 |
| Return visit (30+ min) | 199 | $23,725 | $103 |
| New patient complete exam of visual system | 223 | $22,989 | $103 |
| Removal of recurring cataract in lens capsule using a laser | 57 | $19,063 | $313 |
| New patient visit (45+ min) | 111 | $14,386 | $130 |
| Complex removal of cataract with insertion of prosthetic lens | 15 | $11,757 | $653 |
| Exam of visual field with extended testing | 139 | $11,601 | $55 |
| Imaging of retina | 262 | $10,260 | $32 |
| Exam of the internal drainage system of eye | 353 | $7,807 | $22 |
| Measurement of corneal curvature and depth of eye | 131 | $6,604 | $33 |
| Imaging of optic nerve | 144 | $6,381 | $29 |
| Long return visit (40+ min) | 28 | $5,123 | $151 |
| Exam to measure eye deviation and range of motion | 46 | $2,883 | $57 |
| New patient visit (60+ min) | 16 | $2,532 | $158 |
| New patient problem focused exam of visual system | 19 | $1,200 | $63 |
| Removal of eyelashes using forceps | 12 | $261 | $16 |
| Ultrasound scan of cornea to determine thickness | 15 | $135 | $8 |
2022: 16 services
| Established patient complete exam of visual system | 251 | $26,693 | $100 |
| Removal of cataract with insertion of prosthetic lens | 34 | $25,397 | $446 |
| Return visit (30+ min) | 128 | $17,596 | $99 |
| New patient complete exam of visual system | 149 | $16,727 | $112 |
| Established patient problem focused exam of visual system | 125 | $11,197 | $78 |
| Exam of visual field with extended testing | 113 | $8,432 | $52 |
| New patient visit (45+ min) | 54 | $6,998 | $130 |
| Long return visit (40+ min) | 35 | $6,489 | $144 |
| Exam of the internal drainage system of eye | 274 | $6,295 | $23 |
| Imaging of retina | 161 | $5,502 | $33 |
| Removal of recurring cataract in lens capsule using a laser | 12 | $4,159 | $277 |
| New patient visit (60+ min) | 22 | $3,919 | $178 |
| Imaging of optic nerve | 109 | $3,489 | $30 |
| Measurement of corneal curvature and depth of eye | 64 | $3,396 | $41 |
| Short return visit (20+ min) | 27 | $1,659 | $55 |
| Exam to measure eye deviation and range of motion | 28 | $1,628 | $56 |
2021: 16 services
| Removal of cataract with insertion of prosthetic lens | 40 | $28,415 | $490 |
| Established patient complete exam of visual system | 206 | $23,023 | $101 |
| Return visit (30+ min) | 128 | $18,611 | $102 |
| Long return visit (40+ min) | 42 | $8,641 | $157 |
| Exam of visual field with extended testing | 109 | $8,293 | $56 |
| New patient complete exam of visual system | 85 | $7,431 | $87 |
| Short return visit (20+ min) | 85 | $6,756 | $71 |
| Exam of the internal drainage system of eye | 269 | $6,330 | $24 |
| Imaging of optic nerve | 123 | $4,591 | $31 |
| New patient visit (45+ min) | 29 | $3,622 | $125 |
| Imaging of retina | 87 | $3,511 | $32 |
| New patient visit (60+ min) | 19 | $3,439 | $181 |
| Measurement of corneal curvature and depth of eye | 49 | $3,224 | $47 |
| Exam to measure eye deviation and range of motion | 36 | $2,030 | $52 |
| Extended exam of the back part of the eye with retinal drawing | 11 | $317 | $19 |
| Ultrasound scan of cornea to determine thickness | 11 | $111 | $10 |
2020: 6 services
| New patient complete exam of visual system | 37 | $4,483 | $121 |
| Established patient complete exam of visual system | 36 | $3,790 | $105 |
| Return visit (30+ min) | 14 | $1,394 | $93 |
| Exam of the internal drainage system of eye | 46 | $1,087 | $24 |
| Imaging of optic nerve | 22 | $696 | $32 |
| Imaging of retina | 16 | $559 | $35 |
Medicaid work
$66,800 in 2024
Medicaid paid $66,800 for 1,821 billed services this clinician did in 2024, up to 38 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 219 | $13,912 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 267 | $10,447 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 189 | $7,514 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 146 | $6,102 |
| Return visit (30+ min) | 142 | $5,676 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 163 | $5,472 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 151 | $5,465 |
| GONIOSCOPY | 232 | $5,435 |
| DETERMINATION REFRACTIVE STATE | 256 | $3,208 |
| New patient visit (45+ min) | 39 | $3,109 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 17 | $460 |
| 2024 | 1,821 | 11 | 38 | $66,800 |
| 2023 | 995 | 11 | 36 | $37,523 |
| 2022 | 87 | 3 | 13 | $1,216 |
| 2021 | 379 | 5 | 37 | $23,248 |
| 2020 | 67 | 2 | 20 | $5,589 |
See the largest Medicaid services in earlier years
2023
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 167 | $10,723 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 144 | $5,988 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 101 | $3,461 |
| GONIOSCOPY | 156 | $3,432 |
| Return visit (30+ min) | 76 | $3,361 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 51 | $2,924 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 73 | $2,514 |
| DETERMINATION REFRACTIVE STATE | 133 | $1,654 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 50 | $1,507 |
| New patient visit (45+ min) | 15 | $1,235 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 29 | $724 |
2022
| GONIOSCOPY | 53 | $639 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 18 | $349 |
| DETERMINATION REFRACTIVE STATE | 16 | $228 |
2021
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 107 | $16,434 |
| DETERMINATION REFRACTIVE STATE | 118 | $2,286 |
| GONIOSCOPY | 99 | $1,900 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 42 | $1,783 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 13 | $844 |
2020
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 34 | $4,912 |
| DETERMINATION REFRACTIVE STATE | 33 | $677 |
Drugs they prescribed that Part D paid
$104,842
Pharmacies billed $104,842 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,230) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
585 generic and 645 brand-name prescriptions · $104,842 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 24 | $26,414 | $1,101 |
| Prednisolone Acetate | 318 | $16,429 | $52 |
| Cyclosporine | 15 | $6,785 | $452 |
| Tobramycin-Dexamethasone | 100 | $3,790 | $38 |
| Latanoprost | 200 | $3,158 | $16 |
See all 14 drugs
| Restasis | 24 | $26,414 | $1,101 |
| Prednisolone Acetate | 318 | $16,429 | $52 |
| Cyclosporine | 15 | $6,785 | $452 |
| Tobramycin-Dexamethasone | 100 | $3,790 | $38 |
| Latanoprost | 200 | $3,158 | $16 |
| Loteprednol Etabonate | 12 | $2,129 | $177 |
| Brimonidine | 36 | $1,885 | $52 |
| Dorzolamide-Timolol | 90 | $1,565 | $17 |
| Pyridostigmine | 32 | $1,471 | $46 |
| Neomycin-Polymyxin-Dexameth | 128 | $1,293 | $10 |
| Timolol Maleate | 47 | $637 | $14 |
| Ketorolac Tromethamine | 22 | $409 | $19 |
| Prednisone | 39 | $383 | $10 |
| Moxifloxacin | 13 | $175 | $13 |
Year by year
| 2024 | 1,230 | 490 | 0% (0) | 52% | $104,842 |
| 2023 | 1,304 | 524 | None | 54% | $181,478 |
| 2022 | 1,818 | 533 | 0% (0) | 50% | $306,488 |
| 2021 | 967 | 260 | 0% (0) | 46% | $69,738 |
| 2020 | 66 | 38 | 0% (0) | 27% | $2,353 |
| 2019 | 61 | 31 | None | 41% | $9,617 |
| 2018 | 400 | 112 | 0% (0) | 49% | $38,325 |
| 2017 | 61 | 26 | 0% (0) | 44% | $5,653 |
| 2016 | 16 | 11 | None | None | $2,409 |
| 2015 | 33 | 20 | None | None | $994 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Restasis | 32 | $38,309 | $1,197 |
| Lumigan | 71 | $37,637 | $530 |
| Prednisolone Acetate | 286 | $16,962 | $59 |
| Xiidra | 14 | $11,982 | $856 |
| Combigan | 25 | $11,168 | $447 |
| Latanoprost | 242 | $5,826 | $24 |
| Brimonidine Tartrate-Timolol | 11 | $5,034 | $458 |
| Alphagan P | 13 | $4,301 | $331 |
| Neomycin-Polymyxin-Dexameth | 199 | $2,823 | $14 |
| Timolol Maleate | 52 | $2,683 | $52 |
| Dorzolamide-Timolol | 77 | $2,346 | $30 |
| Tobramycin-Dexamethasone | 37 | $2,328 | $63 |
| Pyridostigmine | 13 | $914 | $70 |
| Dorzolamide | 25 | $602 | $24 |
| Ketorolac Tromethamine | 20 | $479 | $24 |
| Brimonidine | 26 | $373 | $14 |
| Ciprofloxacin | 29 | $333 | $11 |
| Prednisone | 12 | $244 | $20 |
2022: 20 drugs
| Lumigan | 153 | $80,089 | $523 |
| Restasis | 33 | $51,375 | $1,557 |
| Combigan | 56 | $26,781 | $478 |
| Alphagan P | 26 | $17,829 | $686 |
| Prednisolone Acetate | 193 | $13,406 | $69 |
| Travoprost | 38 | $12,872 | $339 |
| Rhopressa | 20 | $11,525 | $576 |
| Latanoprost | 490 | $11,088 | $23 |
| Brimonidine Tartrate-Timolol | 29 | $10,521 | $363 |
| Simbrinza | 30 | $7,662 | $255 |
| Prolensa | 16 | $5,420 | $339 |
| Timolol Maleate | 93 | $5,327 | $57 |
| Travatan Z | 12 | $4,431 | $369 |
| Dorzolamide-Timolol | 143 | $4,404 | $31 |
| Ketorolac Tromethamine | 71 | $2,402 | $34 |
| Neomycin-Polymyxin-Dexameth | 86 | $1,317 | $15 |
| Ciprofloxacin | 76 | $1,035 | $14 |
| Brimonidine | 34 | $1,005 | $30 |
| Dorzolamide | 26 | $866 | $33 |
| Azelastine | 11 | $459 | $42 |
2021: 11 drugs
| Lumigan | 40 | $17,395 | $435 |
| Prednisolone Acetate | 176 | $8,562 | $49 |
| Combigan | 21 | $6,430 | $306 |
| Latanoprost | 240 | $5,636 | $23 |
| Ketorolac Tromethamine | 116 | $3,699 | $32 |
| Timolol Maleate | 37 | $2,944 | $80 |
| Ciprofloxacin | 114 | $1,243 | $11 |
| Neomycin-Polymyxin-Dexameth | 58 | $1,171 | $20 |
| Dorzolamide-Timolol | 35 | $1,050 | $30 |
| Brimonidine | 23 | $300 | $13 |
| Dorzolamide | 12 | $286 | $24 |
2020: 1 drug
| Latanoprost | 16 | $344 | $21 |
2019: 2 drugs
| Timolol Maleate | 11 | $2,100 | $191 |
| Latanoprost | 22 | $363 | $16 |
2018: 11 drugs
| Alphagan P | 34 | $7,536 | $222 |
| Combigan | 19 | $4,535 | $239 |
| Brimonidine | 18 | $2,756 | $153 |
| Simbrinza | 14 | $2,704 | $193 |
| Timolol Maleate | 21 | $2,504 | $119 |
| Durezol | 12 | $2,308 | $192 |
| Latanoprost | 104 | $1,583 | $15 |
| Prednisolone Acetate | 29 | $1,049 | $36 |
| Dorzolamide-Timolol | 32 | $722 | $23 |
| Dorzolamide | 22 | $577 | $26 |
| Neomycin-Polymyxin-Dexameth | 11 | $154 | $14 |
Money from drug and device companies
$216 in 2025
| 2025 | 5 | 8 | None | $216 |
| 2024 | 8 | 11 | None | $236 |
| 2023 | 4 | 10 | None | $302 |
| 2022 | 4 | 4 | None | $99 |
| 2019 | 1 | 3 | None | $113 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Tepezza | $100 | 3 payments
|
| Tarsus Pharmaceuticals | Xdemvy | $40 | 2 payments
|
| Alcon Vision | Clareon | $32 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $27 | 1 payment
|
| Bausch & Lomb Americas | Miebo | $17 | 1 payment
|
See all 8 published payments
| Amgen | Meals · 2025-12-17 | Tepezza | $43 |
| Tarsus Pharmaceuticals | Meals · 2025-09-19 | Xdemvy | $18 |
| Tarsus Pharmaceuticals | Meals · 2025-08-15 | Xdemvy | $23 |
| Amgen | Meals · 2025-06-25 | Tepezza | $30 |
| Alcon Vision | Meals · 2025-05-31 | Clareon | $32 |
| Amgen | Meals · 2025-03-12 | Tepezza | $27 |
| Sun Pharmaceutical Industries | Meals · 2025-02-21 | Cequa | $27 |
| Bausch & Lomb Americas | Meals · 2025-02-06 | Miebo | $17 |
See earlier years (2024, 2023, 2022, 2019)
2024: $236
| Amgen | Tepezza | $82 | 4 payments
|
| Rayner Intraocular Lenses | Omidria | $33 | 1 payment
|
| Dompe US | Oxervate | $26 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $23 | 1 payment
|
| Tarsus Pharmaceuticals | Xdemvy | $20 | 1 payment
|
| Johnson & Johnson Surgical Vision | Tecnis Simplicity | $20 | 1 payment
|
| Biotissue Holdings | None | $18 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $15 | 1 payment
|
2023: $302
| Horizon Therapeutics plc | Tepezza | $213 | 5 payments
|
| Alcon Vision | Clareon | $57 | 3 payments
|
| Bausch & Lomb Americas | Miebo | $18 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $14 | 1 payment
|
2022: $99
| BioTissue Holdings | Prokera | $50 | 1 payment
|
| Travere Therapeutics | Cholbam | $22 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $15 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $12 | 1 payment
|
2019: $113
| Alcon Vision | Acrysof | $113 | 3 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1760877906
- Licence
- NJ 25MA10896300, PA MD467131New Jersey 25MA10896300: Inactive
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 3035 Cleveland Ave Ste 100, Santa Rosa, CA, 95403
- NPI first listed
- 2015-04-04
- NPI last updated
- 2026-06-17
- NPI record certified
- 2026-06-17
This is when the NPI record was last certified, not a medical board exam.